Current report No. 11/2021 – List of shareholders holding at least 5% of the votes at the Extraordinary General Meeting of the Company held on 16 February 2021

February 16, 2021

Legal basis subs. 70 point 3 of the Act on Public Offering – General Shareholder's Meeting, the above 5% list

Content of the report:

Acting pursuant to Article 70 point 3 of the Act on Public Offering [...] Management Board of Celon Pharma S.A. (the “Company”) hereby informs that the shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company held on 16 February 2021 were:

- Glatton sp. z o.o., holder of 30,003,531 shares in the Company, representing 45,003,531 votes, which constituted 75.01% of the total number of votes in the Company and 89.62% of votes at this Extraordinary General Meeting, - Generali Otwarty Fundusz Emerytalny, holder of 3,000,000 shares in the Company, representing 3,000,000 votes, which constituted 5.00% of the total number of votes in the Company and 5.97% of votes at this Extraordinary General Meeting